Whitehawk Therapeutics, Inc. (WHWK) › Capital ExpendituresWhitehawk Therapeutics, Inc. (WHWK) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2016: $113.3K2017: $8.9K2018: $37.9K2019: $237.0K2020: $19.0K2021: $46.0K2022: $444.0K2023: $3.97M2024: $1.65M2025: $552.0K$552.0K2016Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$552.0K-66.6%2024$1.65M-58.4%2023$3.97M+794.6%2022$444.0K+865.2%2021$46.0K+141.8%2020$19.0K-92.0%2019$237.0K+525.0%2018$37.9K+326.2%2017$8.9K-92.1%2016$113.3K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share